| Title: |
105P Immune biomarker analysis of the OVATION-2 trial, a randomized phase I/II study of IL-12 gene therapy IMNN-001 in combination with neo/adjuvant chemotherapy (NACT) in newly-diagnosed advanced epithelial ovarian cancer (EOC) |
| Authors: |
Thaker, P.H.; Richardson, D.L.; Hagemann, A.; Holloway, R.W.; Pothuri, B.; Scalici, J.M.; Reed, M.; Bregar, A.; Darus, C.; Finkelstein, K.; III, C.A. Leath; Bell, M.; Warshal, D.; Mendivil, A.; Musso, L.; Lindborg, S.R.; Anwer, K.; Faller, D.V.; Bradley, W.H. |
| Source: |
ESMO Open ; volume 10, page 105233 ; ISSN 2059-7029 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2025 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.esmoop.2025.105233 |
| Availability: |
https://doi.org/10.1016/j.esmoop.2025.105233; https://api.elsevier.com/content/article/PII:S2059702925011020?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S2059702925011020?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: |
edsbas.BBFACC42 |
| Database: |
BASE |